Infectious Disease Treatment Market Research Report - Global Forecast till 2027

Global Infectious Disease Treatment Market Research Report: By Disease Type (Viral Diseases, Bacterial Diseases, Fungal Diseases, Parasitic Diseases and others), Treatment (Antibiotics, Antivirals, Antifungals, Anti-Parasitic and others), End User (Hospitals & Clinics, Ambulatory Care Centers and others) and Region (the Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2027

ID: MRFR/Pharma/5566-HCR | February 2021 | Region: Global | 90 pages

Please note that the assessment period of report has been updated from 2019-2025 to 2020-2027. Cordially fill the sample form for updated data

Market Scenario


Infectious Disease Treatment Market is expected to exhibit significant growth over the forecast period. The market was valued at approximately USD 179.58 Billion in 2018 is projected to register a CAGR of 7.84% over the forecast period.


Infectious diseases are caused due to organisms such as bacteria, viruses, fungi, or parasites. These diseases can be transmitted through insects, animals or by consuming contaminated food or water or by being exposed to the environment that is infected by these organisms.


Factors such as the rising prevalence of infectious diseases and increasing awareness regarding these diseases are expected to drive the market growth. According to an article published by the World Health Organization (WHO), nearly 50,000 people die suffering from infectious diseases every day.


However, stringent government regulations and low awareness regarding the treatment options in underdeveloped countries are expected to hamper the market growth.


Segmentation


The Global Infectious Disease Treatment Market has been segmented into disease type, treatment, end-user, and region.


Based on disease type, the global infectious disease treatment market has been divided into viral diseases, bacterial diseases, fungal diseases, parasitic diseases, and others.


The global infectious disease treatment market, by treatment, has been segmented into antibiotics, antivirals, antifungals, anti-parasitic, and others.


The global infectious disease treatment market, by end-user, has been segmented into hospitals & clinics, ambulatory care centers, and others.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The infectious disease treatment market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.


The European infectious disease treatment market has been segmented into Western Europe and Eastern Europe. The market in Western Europe has further been classified into France, Germany, Spain, the UK, Italy, and the rest of Western Europe. 


The infectious disease treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.


The Middle East & Africa infectious disease treatment market has been segmented into the Middle East and Africa.


Key Players


Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (US), Janssen Global Services, LLC (US), Sanofi (France), GlaxoSmithKline PLC (UK), Novartis AG (Switzerland), Bristol-Myers Squibb Company (US), Bayer AG (Germany), Eli Lilly and Company (US), Astellas Pharma Inc. (Japan), Merck & Co., Inc. (US), Aurobindo Pharma (India), Dr. Reddy's Laboratories (India), Cipla Inc. (India), Alkem Labs (India), AbbVie Inc. (US) are some of the key players operating in the global infectious disease treatment market.


Regional Market Summary


Global Infectious Disease Treatment Market Share (%), by Region, 2018  Infectious Disease Treatment Market


Source: Centers for Disease Control and Prevention (CDC), Eurostat, White Papers, Company Presentations, and Annual Reports


Geographically, the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is anticipated to dominate the infectious disease treatment market owing to the increasing patient population suffering from various types of infectious disease and the growing number of initiatives taken by the government to manage the spread of infectious diseases in the region. According to the Centers for Disease Control and Prevention, there were 54,285 new cases of Salmonella infection in 2017 in the US.


Europe is expected to hold the second-largest position in the global infectious disease treatment market owing to the growing awareness and rising patient population suffering from various infectious diseases. According to the WHO, as of 2018, 14 million people in Europe are suffering from hepatitis C.


Asia-Pacific is expected to be the fastest-growing regional market owing to the high patient population suffering from bacterial infectious diseases and the rising number of initiatives taken by governments as well as private institutes to create awareness regarding infectious diseases. According to an article published by the National Center for Biotechnology Information (NCBI) in May 2018, nearly 22% of deaths of children below the age of 5 years in India are caused due to meningitis and pneumonia.


The infectious disease treatment market in the Middle East & Africa is expected to grow slowly, owing to the rising patient population suffering from various types of infectious diseases.


Global Infectious Disease Treatment Market, by Disease Type



  • Viral Diseases

  • Bacterial Diseases

  • Fungal Diseases

  • Parasitic Diseases

  • Others


Global Infectious Disease Treatment Market, by Treatment



  • Antibiotics

  • Antivirals

  • Antifungals

  • Anti-Parasitic

  • Others


Global Infectious Disease Treatment Market, by End User



  • Hospitals and Clinics

  • Ambulatory Care Centers

  • Others


Global Infectious Disease Treatment Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America





  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • Africa




Intended Audience



  • Biotechnology and Pharmaceutical Companies

  • Research Institutes

  • Hospitals and Clinics

  • Ambulatory Surgical Centers

  • Academic Institutes

  • Government Organizations



Report Scope:
Report Attribute/Metric Details
  Market Size   2025: Significant Value
  CAGR   7.84% (2019-2025)
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Disease Type, Treatment, End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (US), Janssen Global Services, LLC (US), Sanofi (France), GlaxoSmithKline PLC (UK), Novartis AG (Switzerland), Bristol-Myers Squibb Company (US), Bayer AG (Germany), Eli Lilly and Company (US), Astellas Pharma Inc. (Japan), Merck & Co., Inc. (US), Aurobindo Pharma (India), Dr. Reddy's Laboratories (India), Cipla Inc. (India), Alkem Labs (India), AbbVie Inc. (US)
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Factors such as the rising prevalence of infectious diseases.
  • increasing awareness regarding these diseases are expected to drive the market growth


  • Frequently Asked Questions (FAQ) :


    Infectious disease treatment market is projected to grow at a 7.84% CAGR between 2019-2025.

    The Americas is expected to lead the infectious disease treatment market.

    Increasing prevalence of infectious diseases and rising awareness are the key factors driving the infectious disease treatment market.

    Strict government regulations may limit the infectious disease treatment market.

    Different end users of the infectious disease treatment market include ambulatory care centers, hospitals and clinics, and others.